Roivant Sciences Ltd (FRA:87S)
€ 11.525 0.15 (1.32%) Market Cap: 8.62 Bil Enterprise Value: 3.56 Bil PE Ratio: 2.21 PB Ratio: 1.78 GF Score: 60/100

Q4 2023 Roivant Sciences Ltd Earnings Call Transcript

Jun 28, 2023 / 12:00PM GMT
Release Date Price: €7.95 (-0.62%)
Operator

Good day, and thank you for standing by. Welcome to the Roivant Sciences Fourth Quarter and Fiscal Year 2022 Earnings Call. At this time, all participants are in listen on the mode. After the speaker's presentation, there will be a question-and-answer session. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Stephanie Lee with Roivant. Your line is open.

Stephanie Lee Griffin
Roivant Sciences Ltd. - VP of Special Projects

Good morning, and thank you for joining today's call to review Roivant's financial results from the company's fourth quarter and fiscal year ended March 31, 2023. I'm Stephanie Lee with Roivant Sciences. Presenting today, we have Matt Gline, CEO of Rogan. For those dialing in via conference call, you can find the slides being presented today as well as the press release and now can be updated on our IR website at www.investor.agan.com. We'll also be providing the current

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot